ID   OIG4_CAEEL              Reviewed;         155 AA.
AC   Q5WRU0;
DT   07-SEP-2016, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   12-AUG-2020, entry version 112.
DE   RecName: Full=Immunoglobulin domain-containing protein oig-4 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=oig-4 {ECO:0000312|WormBase:R07G3.9};
GN   ORFNames=R07G3.9 {ECO:0000312|WormBase:R07G3.9};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH UNC-29 AND LEV-10, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF GLY-84.
RX   PubMed=21252855; DOI=10.1038/emboj.2010.355;
RA   Rapti G., Richmond J., Bessereau J.L.;
RT   "A single immunoglobulin-domain protein required for clustering
RT   acetylcholine receptors in C. elegans.";
RL   EMBO J. 30:706-718(2011).
CC   -!- FUNCTION: Required for the localization of acetylcholine receptors at
CC       neuromuscular junctions and for subsequently controlling the response
CC       evoked by receptor stimulation. {ECO:0000269|PubMed:21252855}.
CC   -!- SUBUNIT: Interacts with the non-alpha subunit of nicotinic
CC       acetylcholine receptor unc-29 and lev-10 to stabilize the complex
CC       formed between unc-29 and lev-10. {ECO:0000269|PubMed:21252855}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse
CC       {ECO:0000269|PubMed:21252855}. Secreted {ECO:0000269|PubMed:21252855}.
CC       Note=Secreted by body wall cells. Co-localizes with and requires
CC       acetylcholine receptors for localization at neuromuscular junctions.
CC       {ECO:0000269|PubMed:21252855}.
CC   -!- TISSUE SPECIFICITY: Expressed in body wall muscle cells, the pharyngeal
CC       muscle cell pm6 and in four head neurons.
CC       {ECO:0000269|PubMed:21252855}.
CC   -!- DISRUPTION PHENOTYPE: Disrupted localization of levamisole-sensitive
CC       nicotinic acetylcholine receptor subunits in 80% of mutants, and this
CC       is mostly in conjunction with the disrupted localization of the
CC       associated transmembrane protein lev-10 and secreted protein lev-9.
CC       This results in increased sensitivity to the acetylcholine agonist
CC       levamisole. {ECO:0000269|PubMed:21252855}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX284602; CCD70521.1; -; Genomic_DNA.
DR   RefSeq; NP_001022278.1; NM_001027107.4.
DR   SMR; Q5WRU0; -.
DR   IntAct; Q5WRU0; 2.
DR   MINT; Q5WRU0; -.
DR   STRING; 6239.R07G3.9; -.
DR   PaxDb; Q5WRU0; -.
DR   EnsemblMetazoa; R07G3.9.1; R07G3.9.1; WBGene00043050.
DR   GeneID; 259448; -.
DR   KEGG; cel:CELE_R07G3.9; -.
DR   UCSC; R07G3.9; c. elegans.
DR   CTD; 259448; -.
DR   WormBase; R07G3.9; CE37545; WBGene00043050; oig-4.
DR   eggNOG; ENOG502RYK7; Eukaryota.
DR   GeneTree; ENSGT00970000196744; -.
DR   HOGENOM; CLU_120649_0_0_1; -.
DR   InParanoid; Q5WRU0; -.
DR   OMA; KWYKEGA; -.
DR   OrthoDB; 1418131at2759; -.
DR   PhylomeDB; Q5WRU0; -.
DR   PRO; PR:Q5WRU0; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00043050; Expressed in multi-cellular organism and 3 other tissues.
DR   GO; GO:0005615; C:extracellular space; IDA:WormBase.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:WormBase.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Disulfide bond; Glycoprotein; Immunoglobulin domain;
KW   Reference proteome; Secreted; Signal; Synapse.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..155
FT                   /note="Immunoglobulin domain-containing protein oig-4"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_5004263494"
FT   DOMAIN          73..154
FT                   /note="Ig-like C2-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   CARBOHYD        55
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        114
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   DISULFID        80..136
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   MUTAGEN         84
FT                   /note="G->R: In kr39; the mutant protein is intracellularly
FT                   retained in body wall muscle cells and not localized to
FT                   neuromuscular junctions."
FT                   /evidence="ECO:0000269|PubMed:21252855"
SQ   SEQUENCE   155 AA;  17556 MW;  01EE06255415CA0A CRC64;
     MSFRLWGRCI FFFCFLLEAI DSRGGRRGGK GKGKSNLQFA QVAEFSLVQT VLSDNRSAQI
     ITGSHFSQTY RLGYKLLIIC KARGDPRPTI KWYKEGAEIQ PKASIHYYEK PIENDTIWSK
     LEVDPATMGD QGVYACVANN PHGVMAKNFK AEYTY
//
